Richman Michael 4
4 · NextCure, Inc. · Filed Feb 1, 2024
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Richman Michael
DirectorPresident & CEO
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-01-31+305,500→ 305,500 totalExercise: $1.22Exp: 2034-01-30→ Common Stock (305,500 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025.